Sort by 'likes'
Understanding the approach to integrative oncology
Research suggests that cancer patients are interested in using additional interventions that may help improve the efficacy of conventional cancer treatments, increase their chance of survival, and/or reduce their symptom burden associated with cancer or treatments. They are also looking…
Myeloma 2015. Year in Review with the MMRF
2015 saw a lot of action in the Myeloma world. Four new drugs were approved by the FDA increasing treatment options and allowing new combination regimens; promising immunotherapy research results will see these being used in clinical practice and 1000…
What To Eat? with Dr. Colin Campbell (China Study) and Dr. Kaayla Daniel (The Weston A Price Foundation)
We are what we eat. But what do we eat? Should we be eating meat? Or is a plant-based diet a healthier way of eating? Searching for answers on the World Wide Web inevitably leads to more questions, making us…
Understanding ASCENT Clinical Trial for High Risk Smoldering Myeloma Patients
This is the first of a 3 part series of talk on high risk smoldering myeloma and its treatments. Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder. There have been major advances in the diagnosis, prognosis, and…
ASCO 2019 Highlights: Advances in Multiple Myeloma
ASCO 2019 conluded on 4th June 2019 and we are excited about Multiple Myeloma updates from the largest gathering of oncologists, researchers and health professionals. The myeloma panel is talking to Dr. Joseph Mikhael, Professor, Applied Cancer Research and Drug…